Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P54
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -2.14% |
| Q3 2025 | -16.04% |
| Q2 2025 | 11.33% |
| Q1 2025 | -25.13% |
| Q4 2024 | -14.06% |
| Q3 2024 | -34.38% |
| Q2 2024 | 29.22% |
| Q1 2024 | -124.37% |
| Q4 2023 | 30.89% |
| Q3 2023 | 9.17% |
| Q2 2023 | -18.57% |
| Q1 2023 | -58.66% |
| Q4 2022 | 32.00% |
| Q3 2022 | -40.17% |
| Q2 2022 | 40.22% |
| Q1 2022 | -73.46% |
| Q4 2021 | -7.99% |
| Q3 2021 | 40.64% |
| Q2 2021 | -154.80% |
| Q1 2021 | 11.35% |
| Q4 2020 | -72.57% |
| Q3 2020 | -62.95% |
| Q2 2020 | 1.56% |
| Q1 2020 | -57.84% |
| Q4 2019 | -28.23% |
| Q3 2019 | -47.46% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | -151.66% |
| Q3 2017 | 141.96% |
| Q2 2017 | -5.08% |
| Q1 2017 | 395.00% |
| Q4 2016 | -113.47% |
| Q3 2016 | 1000.00% |
| Q2 2016 | -126.19% |
| Q1 2016 | 140.38% |
| Q4 2015 | -222.83% |
| Q3 2015 | 1007.14% |
| Q2 2015 | 70.53% |
| Q1 2015 | 61.07% |